Chemotherapy at First Diagnosis of Advanced Prostate Cancer – Revolution or Evolution? Findings from a British Uro-oncology Group UK Survey to Evaluate Oncologists' Views on First-line Docetaxel in Combination with Androgen Deprivation Therapy in Castrate-sensitive Metastatic and High-risk/Locally Advanced Prostate Cancer

Autor: Davda, R. ∗, Hughes, S. †, Jones, R. ‡, Crabb, S.J. §, Troup, J. , Payne, H. ∗
Zdroj: In Clinical Oncology June 2016 28(6):376-385
Databáze: ScienceDirect
Externí odkaz: